by The global Human augmentation market size was estimated to be around US$ 330.38 billion in 2023 and is projected to reach US$ 1,117.53 billion by 2032, indicating a CAGR of 14.50% from 2023 to 2032.
Key Takeaways
- North America contributed more than 46% of the market share in 2022.
- Asia-Pacific is estimated to witness the fastest CAGR between 2023 and 2032.
- By type, the wearable segment has held the largest market share of 61% in 2022.
- By type, the In-built segment is anticipated to grow at a remarkable CAGR of 15.1% between 2023 and 2032.
- By product, the body worn segment generated over 58% of market share in 2022.
- By product, the non-body worn segment is expected to expand at the fastest CAGR over the projected period.
- By technology, the wearable segment generated over 46% of market share in 2022.
- By technology, the virtual reality segment is expected to expand at the fastest CAGR over the projected period.
- By end-user, the consumer segment had the largest market share of 32% in 2022.
- By end-user, the medical segment is expected to expand at the fastest CAGR over the projected period.
The market research report on the Human augmentation market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of Human augmentation products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.
Get a Sample: https://www.precedenceresearch.com/sample/3645
Human Augmentation Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 14.50% |
| Market Size in 2023 | USD 330.38 Billion |
| Market Size by 2032 | USD 1,117.53 Billion |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Type, By Product, By Technology, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Genitourinary Drugs Market Size to Garner USD 32.27 Billion by 2032
The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.
Focusing on the global Human augmentation market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the Human augmentation market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.
Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of Human augmentation products across different countries and applications.
Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.
The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.
This in-depth research report offers valuable insights into the Human augmentation market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.
The competitive landscape section of the report provides detailed information on Human augmentation market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the Human augmentation market.
Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Recent Developments
- In 2022, Paris-based Wandercraft secured USD 45 million in funding to advance the commercialization of its self-balancing exoskeleton. Utilizing algorithms to maintain equilibrium during movement, the new model, priced at €150k to €200k, is deployed in hospitals. Currently, 14 European institutions have adopted this innovative technology.
- In 2022, DASA (Defense and Security Accelerator) introduced an Innovation Focus Area (IFA) named Human Augmentation (HA) to explore Generation-After-Next technologies for security and defense. Seeking proposals for GAN solutions, DASA aims to address UK security challenges by enhancing human performance to maximize operational impact in defense applications.
- In 2022, Japanese researchers have created a wearable robotic “sixth finger” for human augmentation, exploring how the brain adapts to additional body parts. Positioned beside the pinky, the device uses four sensors on the lower arm to analyze electrical signals from muscles, exemplifying advancements in wearable robotics for enhanced human capabilities.
Human Augmentation Market Players
- Ekso Bionics Holdings, Inc.
- ReWalk Robotics Ltd.
- Cyberdyne Inc.
- Touch Bionics Inc. (Össur)
- B-Temia Inc.
- Wandercraft
- Rex Bionics Ltd.
- Wearable Robotics SRL
- Hocoma AG (DIH Technologies)
- Huawei Technologies Co., Ltd.
- Samsung Electronics Co., Ltd.
- Google LLC (Alphabet Inc.)
- Facebook Reality Labs (Meta Platforms, Inc.)
- Sony Corporation
- Microsoft Corporation
Segments Covered in the Report
By Type
- In-Built
- Wearable
By Product
- Body Worn
- Non-body Worn
By Technology
- Wearable
- Virtual Reality
- Augmented Reality
- Exoskeleton
- Intelligent Virtual Assistants
By End User
- Consumer
- Commercial
- Medical
- Defense
- Industrial
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Human Augmentation Market
5.1. COVID-19 Landscape: Human Augmentation Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Human Augmentation Market, By Type
8.1. Human Augmentation Market, by Type, 2023-2032
8.1.1. In-Built
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Wearable
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Human Augmentation Market, By Product
9.1. Human Augmentation Market, by Product, 2023-2032
9.1.1. Body Worn
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Non-body Worn
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Human Augmentation Market, By Technology
10.1. Human Augmentation Market, by Technology, 2023-2032
10.1.1. Wearable
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Virtual Reality
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Augmented Reality
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Exoskeleton
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Intelligent Virtual Assistants
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Human Augmentation Market, By End User
11.1. Human Augmentation Market, by End User, 2023-2032
11.1.1. Consumer
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Commercial
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Medical
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Defense
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Industrial
11.1.5.1. Market Revenue and Forecast (2020-2032)
11.1.6. Others
11.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Human Augmentation Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2020-2032)
12.1.2. Market Revenue and Forecast, by Product (2020-2032)
12.1.3. Market Revenue and Forecast, by Technology (2020-2032)
12.1.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Technology (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Technology (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.3. Market Revenue and Forecast, by Technology (2020-2032)
12.2.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Technology (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Technology (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Technology (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Product (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Technology (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.3. Market Revenue and Forecast, by Technology (2020-2032)
12.3.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Technology (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Technology (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Technology (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Product (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Technology (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.3. Market Revenue and Forecast, by Technology (2020-2032)
12.4.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Technology (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Technology (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Technology (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Product (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Technology (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.5.3. Market Revenue and Forecast, by Technology (2020-2032)
12.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Product (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Technology (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Product (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Technology (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End User (2020-2032)
Chapter 13. Company Profiles
13.1. Ekso Bionics Holdings, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. ReWalk Robotics Ltd.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Cyberdyne Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Touch Bionics Inc. (Össur)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. B-Temia Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Wandercraft
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Rex Bionics Ltd.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Wearable Robotics SRL
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Hocoma AG (DIH Technologies)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Huawei Technologies Co., Ltd.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
